UPCOMING EVENTS
Zurich Life Science Day 2022
Digital
Zurich Life Science Day 2022
The largest life science career day in Switzerland. From to
If you are a life scientist, student, or postgraduate, looking for opportunities or just curious and interested in exploring new career paths, then the Zurich Life Science Day is the right event for you! Don't miss your chance to talk to company representatives and to discover the different aspects of the industry through interesting talks and informal meetings. Connect and broaden your network on February 8th, 2022 at the 13th edition of Zurich Life Science Day!
Life Science Zurich Young Scientist Network is a non-profit organization created and run by a group of graduate students & post-docs of the University of Zurich and the ETH Zurich.
Kontakttag Life Science FHNW 2022
Digital
Kontakttag 2022
From to
The School of Life Sciences FHNW, located in Muttenz near Basel, is part of the largest life sciences location in Europe. At the "Kontakttag 2022", students have the opportunity to learn more about career opportunities at CARBOGEN AMCIS and to get in touch with us. We are looking forward to a inspiring exchange.
ChemSpec Europe 2022
Messe Frankfurt
CS-G80, Hall 12.1
ChemSpec Europe 2022
From to
COVID-19, sustainability, new trends, and digitalisation are not just buzzwords. In fact, these aspects and the ongoing demand for innovations determine the industry.
The choice of the right suppliers and the exchange of knowledge within international industry networks is more important than ever. With a highly specialised exhibition profile, Chemspec Europe 2022 is a key event for buyers, traders and agents in search of bespoke solutions and innovative substances.
The 36th International Exhibition for Fine and Speciality Chemicals will take place from 31 May - 01 June 2022 at Messe Frankfurt, Germany.
Stereochemistry - Gordon Research Conference (GRC)
Salve Regina University in Newport RI, United States
Stereochemistry - Gordon Research Conference (GRC) 2022
From to
Stereochemistry is everywhere and indeed without chirality life itself would not exist. The 2022 Gordon Research Conference on Stereochemistry will feature some of the most exciting advances in synthesis and catalysis, natural products, macromolecular chemistry, and methodology development.
The 2022 GRC on Stereochemistry will bring together world experts in these fields to stimulate an exchange of ideas that will advance the field and lead to new areas of inquiry. The conference will include 29 speakers divided into nine sessions, as well as four poster sessions, wherein attendees will share their most recent, often unpublished, results. There will be an opportunity for additional informal discussions during the afternoons and during mixers after the evening lectures.
CPhI Worldwide 2022
Messe Frankfurt
120F81
CPhI Worldwide 2022
From to
CPhI Worldwide will return to Frankfurt from 01st November to 03rd November 2022.
Over the last 30+ years, CPhI has provided a unique platform that unites specialist communities dedicated to improving healthcare. We offer a place where professionals can meet to exchange knowledge and do business without obstacles, helping to propel the pharmaceutical and healthcare industries forward.
LATEST NEWS
Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.
NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.
CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland
BUBENDORF, Switzerland (27 October 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at the site in Aarau, Switzerland.
CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client
BUBENDORF, Switzerland (27 Aug 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today the signing of a co-investment agreement with one of its key European customers.
CARBOGEN AMCIS acquires new property at Bubendorf site
BUBENDORF, Switzerland (24 June, 2021) Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced the acquisition of a new property in Bubendorf.
CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site
BUBENDORF, Switzerland (April 29th, 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today a joint funding agreement with a long standing Japan based customer to build a site extension at the Bubendorf site in Switzerland.
For more information
download our Company Profile
brochure or contact us today.
